Michael Kaseta - Jan 31, 2025 Form 4/A - Amendment Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/Ira Duarte Attorney-in-fact for Michael Kaseta
Stock symbol
HRTX
Transactions as of
Jan 31, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/4/2025, 05:40 PM
Date Of Original Report
Feb 3, 2025
Previous filing
Feb 3, 2025
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +18K +47.39% $0.00 55.8K Jan 31, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $0 +35.9K $0.00 35.9K Jan 31, 2025 Common Stock 35.9K $1.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.